ArticlePLoS pathogens2025
Rare metabolic gene essentiality is a determinant of microniche adaptation in Eschherichia coli.
Article in PLoS pathogens, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Identification of specific metabolic capacities associated with major extraintestinal pathogenicJournal of bacteriology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Rare genes in bacterial pangenomes have historically been considered non-essential, dispensable, or even costly, and largely excluded from in-depth analyses due to their perceived redundancy, high variability, and presumed neutral evolutionary origin. However, whether rare genes contribute to metabolic robustness when core genes are lost remains an open question. In this study, we systematically investigate the role of rare metabolic genes in Escherichia coli, revealing their essentiality in maintaining metabolic functions under core gene loss. Through a pangenome-scale reconstruction of 15311 strain-specific genome-scale models (panGEM) and over 22.4 million gene knockout simulations, we demonstrate that: (i) 9.4% of rare metabolic genes are essential in at least one of three key host environments-feces, serum, and urine; (ii) 41% of strains rely on at least one rare essential metabolic gene for survival; (iii) rare metabolic genes emerge as a result of microniche adaptation, and (iv) panGEM allows for the prediction of a subset of highly conserved metabolic reactions with minimal genetic diversity as stable drug targets. These findings challenge the common view that rare genes primarily serve as evolutionary byproducts of genome fluidity and reveal their critical role in metabolic resilience.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.